Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial

Article Abstract:

The drug sibutramine in combination with behavior therapy may be effective in treating obesity in teenagers, according to a study of 82 obese teenagers. However, the FDA has not approved this drug for use in anyone under the age of 16. Consequently, it should only be used on an experimental basis until more data can be collected on its safety and effectiveness.

Behavior therapy, Obesity in adolescence, Adolescent obesity, Behaviour therapy

---

Long-term Weight Loss With Sibutramine: A Randomized Controlled Trial

Article Abstract:

The drug sibutramine appears to be effective in promoting weight loss in obese people, according to a study of 1,001 people who took the drug or a placebo for one year. The occurrence of side effects can be minimized by discontinuing the drug for a few weeks periodically. This intermittent treatment was as effective as continuous treatment.

Drug therapy, Weight reducing preparations, Anti-obesity agents

---

Randomized trial of lifestyle modification and pharmacotherapy for obesity

Article Abstract:

A study was conducted with fourth treatment group to assess the efficacy of sibutramine combined with brief lifestyle-modification counseling delivered by primary care providers. The combination of medication and group lifestyle modification resulted in more weight loss than either medication or lifestyle modification alone.

United States, Health aspects, Clinical trials, Life style, Lifestyles, Dosage and administration

Similar abstracts:

• Abstracts: Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast
• Abstracts: Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. A major outbreak of severe acute respiratory syndrome in Hong Kong
• Abstracts: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.